| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |